Enhanced Tumor Killing by Apo2L/Trail and CPT-11 Co-Treatment Is Associated With P21 Cleavage and Differential Regulation of Apo2L/Trail Ligand and Its Receptors
Oncogene - United Kingdom
doi 10.1038/sj.onc.1205449
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2002
Authors
Publisher
Springer Science and Business Media LLC